Strain-Dependent Differences in the Expression of the Oncofetal Protein p65 in Mice Susceptible and Resistant to Chemical Carcinogenesis

  • Janusz Szemraj
  • Margaret Hanausek
  • Zbigniew Walaszek
  • Alan K. Adams
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 14)


The 65-kDa oncofetal protein (p65), a novel tumor marker (1, 2, 3, 4, 5, 6, 7), is highly conserved m different species (2,4). We have identified the p65 gene as a novel member of the family of genes that encode receptors for steroid hormones, vitamin D, retmoic acid and thyroid hormone (7). The p65 protein is highly homologous to estrogen receptor (ER) m its DNA binding domain but other regions of the sequence do not show similarities, indicating that p65 is a new transcription factor or receptor with an as yet unknown ligand. Using enzymelmked immunosorbent assay (ELISA) and immunostaining, p65 was shown (5,6), to be a promismg marker for diagnosis and prognosis of cancer. With a view toward early detection of cancer, we have studied strain-dependent differences in the expression of p65 in different organs of mice highly susceptible (C3H/HeJ) and relatively resistant (C57BL/6N) to carcinogenesis. In this chapter, we describe a new, general procedure for detection of p65 mRNA by reverse transcription polymerase chain reaction (RT-PCR). This method is sensitive enough to detect a small number of the p65-specific mRNA molecules in mammary glands and livers of young, 7–8 wk-old female mice of the C3H/HeJ strain are known to spontaneously develop mammary tumors and be sensitive to liver tumor induction. No p65-specific mRNA was detected in a control group of C57BL/6N mice known to be resistant to chemical carcmogenesis.


Mammary Gland Reverse Transcription Polymerase Chain Reaction Mouse Mammary Tumor Virus Guanidinium Isothiocyanate Polymerase Reaction Buffer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hanausek-Walaszek M., Del Rio M., and Adams A K. (1989) Immunohlstochemical demonstration of mRNA-transport protein in rat liver putative preneoplastic foci. Cancer Lett 48, 105–108.CrossRefGoogle Scholar
  2. 2.
    Hanausek-Walaszek M, Del Rio M, and Adams A K. (1990) Structural and immunological identity of p65 tumor-associated factors from rat and mouse hepatocarcmomas. Progr Cfin Bzol Res 331, 109–120.Google Scholar
  3. 3.
    Mirowski M, Sherman U, and Hanausek M (1992) Purification and characterization of a 65-kDa tumor-associated phosphoprotem from rat transplantable hepatocellular carcinoma 1682C cell line. Protein Expr Purif 3, 196–203PubMedCrossRefGoogle Scholar
  4. 4.
    Mirowskl M., Walaszek Z, Sherman U., Adams A. K, and Hanausek M (1993) Comparative structural analysis of human and rat 65 kDa phosphoprotein Int J Blochem 25, 1865–1871CrossRefGoogle Scholar
  5. 5.
    Wang S., Mirowski M., Sherman U., Walaszek Z., and Hanausek M. (1993) Monoclonal antibodies against a 65 kDa tumor-associated phosphoprotem development and use in cancer detection. Hybridoma 12, 167–176.PubMedCrossRefGoogle Scholar
  6. 6.
    Mirowski M., Klijanienko J., Wang S., Vielh P., Walaszek Z, and Hanausek M (1994) Serological and immunohistochemical detection of a 65 kDa protein breast cancer Eur J Cancer 30A, 1108–1113PubMedCrossRefGoogle Scholar
  7. 7.
    Hanausek M, SzemraJ J., Adams A. K., and Walaszek Z. (1996) The oncofetal protein p65. a new member of the steroid/thyroid receptor superfamily Cancer Detect Prev 20, 94–102.PubMedGoogle Scholar
  8. 8.
    Bennet L M., Famham P. J., and Drinkwater N R. (1995) Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of C57B1/6J and C3H/HeJ mice Moi Carcinogenesis 14, 46–52CrossRefGoogle Scholar
  9. 9.
    Drinkwater N R. and Ginsler J. J (1986) Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcmogenesis 7, 1701–1707.CrossRefGoogle Scholar
  10. 10.
    Bennett L. M., Winkler M. L, and Drinkwater N. R. (1993) A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc Am Assoc Cancer Res 33, 144Google Scholar
  11. 11.
    Gariboldi M., Manenti G., Canzian F., Falvella S., Pierotti M, Della Porta G., and Dragani T. A (1993) Chromosomal mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53, 209–211.PubMedGoogle Scholar
  12. 12.
    Manenti G, Binelli G, Gariboldi M, Canzian F, De Gregoriol R, Flavella S, Dragani T. A., and Pierotti M (1994) Multiple loci affect genetic predispositton to hepatocarcinogenesis in mice Genomics 23, 118–124PubMedCrossRefGoogle Scholar
  13. 13.
    Medina D (1976) Preneoplastic lesions in murine mammary cancer Cancer Res 36, 2589–2595PubMedGoogle Scholar
  14. 14.
    Schwartz M S., Smith G H., and Medina D. (1992) The effect of parity, tumor latency and transplantation of the activation of int loct in MMTV-induced, transplantal C3H mammary neoplasias and their tumors. Int J Cancer 51, 805–811.PubMedCrossRefGoogle Scholar
  15. 15.
    Dux A (1981) Sensitivity of the mammary gland to tumor formation, in Mammary Tumors in the Mouse (Hilgers J. and Skryser M., eds.), Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands, 516–543Google Scholar
  16. 16.
    Festing M F. W. and Blackmore D. K. (1971) Life span of specified-pathogen-free (MRC category 4) mice and rats Lab Anlm (Lond) 5, 179–192Google Scholar
  17. 17.
    Burmer G C. and Loeb L A. (1989) Mutations in the K-ras 2 oncogene during progressive stages of human colon carcinoma. Proc Natl. Acad. Sci USA 86, 2403–2407PubMedCrossRefGoogle Scholar
  18. 18.
    Burmer G. C, Parker J D, Bates J, East K., and Kulander B G (1990) Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype Am J Clin Pathol 94, 554–560PubMedGoogle Scholar
  19. 19.
    Burmer G. C., Rabinovitch P S, and Loeb L. A. (1989) Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction and DNA sequencing. Cancer Res. 49, 214l–2146.Google Scholar
  20. 20.
    Frohman M. A., Dush M K., and Martin G. R (1988) Rapid productton of full-length cDNAs from rare transcripts. amplification using single gene specific oligonucleotide primer. Proc Nat1 Acad Scl USA 85, 8998–9002CrossRefGoogle Scholar
  21. 21.
    Higuchi R, von Beroldingen C H, Sensabaugh G F, and Erlich H A. (1988) DNA typing from single hairs Nature 333, 543-540Google Scholar
  22. 22.
    Saiki R K, Gelfand D H, Stoffel S., Scharf S J., Higuchi R, Horn G. T, Mullis K B., and Erlich H. A (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Sczence 39, 487–491.CrossRefGoogle Scholar
  23. 23.
    Erlich H. A (1989) PCR Technology Prlnclples and Appllcatlons for DNA Amplrjkatton. Stockton, New York.Google Scholar
  24. 24.
    Ponce R. P and Micol J L (1992) PCR amplification of long DNA fragments Nucleic Acids Res 20, 3–623CrossRefGoogle Scholar
  25. 25.
    D’Aquaila R. T., Bechtel L. J, Videler J A., Eron J J., Gorczyca P, and Kaplan J. C. (1991) Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 19, 3749–3754CrossRefGoogle Scholar
  26. 26.
    Hanausek-Walaszek M, Adams A. K., and Sherman U. (1991) Expression of a 65 kda tumor-associated protein and persistence of altered hepatic faci. Progr Clm Blol Res 369, 91–103Google Scholar
  27. 27.
    Hanausek M., Sherman U., Mirowski M, and Walaszek Z Induction of a 65 kDa tumor-associated protein in altered hepatic foci of rats fed the peroxisome proliferator Wy-14,643 Progr Clan Biol Res 387, 337–348Google Scholar
  28. 28.
    Ponglikitmongkol M., Green S., and Chambon P (1988) Genomic organization of the human oestrogen receptor gene EMBO J 7, 3385–3388PubMedGoogle Scholar

Copyright information

© Humana Press Inc, Totowa, NJ 1998

Authors and Affiliations

  • Janusz Szemraj
    • 1
  • Margaret Hanausek
    • 2
  • Zbigniew Walaszek
    • 2
  • Alan K. Adams
    • 1
  1. 1.Department of CarcinogenesisThe University of Texas M.D. Anderson Cancer CenterSmithville
  2. 2.AMC Cancer Research CenterDenver

Personalised recommendations